Legato Capital Management LLC Xenon Pharmaceuticals Inc. Transaction History

Legato Capital Management LLC

  • $761 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
BUY
$42.66 - $50.04 $181,219 - $212,569
4,248 Added 35.89%
16,085 $692,000
Q4 2023

Jan 16, 2024
BUY
$28.7 - $46.46 $4,448 - $7,201
155 Added 1.33%
11,837 $545,000
Q3 2023

Oct 12, 2023
BUY
$34.16 - $39.73 $399,057 - $464,125
11,682 New
11,682 $399,000
Q2 2023

Aug 17, 2023
BUY
$34.84 - $43.54 $428,880 - $535,977
12,310 New
12,310 $473,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email